As of 2025-07-03, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -33.59 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 12.44 USD, the upside of Forte Biosciences Inc is -370.01%.
Based on its market price of 12.44 USD and our intrinsic valuation, Forte Biosciences Inc (FBRX) is overvalued by 370.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -33.59 - -33.59 | -33.59 | -370.01% |
| P/E | (114.34) - (158.54) | (141.58) | -1238.1% |
| DDM - Stable | (39.30) - (114.93) | (77.12) | -719.9% |
| DDM - Multi | (25.73) - (61.71) | (36.67) | -394.8% |
| Market Cap (mil) | 81.86 |
| Beta | 2.29 |
| Outstanding shares (mil) | 6.58 |
| Enterprise Value (mil) | 36.00 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.61% |
| Cost of Debt | 5.00% |
| WACC | 8.14% |